Joel David Mayersohn - 31 Dec 2021 Form 5 Insider Report for QSAM Biosciences, Inc. (QSAM)

Role
Director
Signature
/s/ Joel Mayersohn
Issuer symbol
QSAM
Transactions as of
31 Dec 2021
Transactions value $
$0
Form type
5
Filing time
14 Feb 2022, 20:57:28 UTC
Next filing
13 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QSAM COMMON STOCK Award $0 +400,000 $0 400,000 15 Dec 2021 Direct F1
holding QSAM COMMON STOCK 428,616 31 Dec 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QSAM Options to buy common stock Award $0 +54,000 $0 54,000 24 Aug 2021 Common Stock 54,000 $0.36 Direct F3
holding QSAM Options to buy common stock 37,840 31 Dec 2021 Common Stock 39,840 $0.5 Direct F4
holding QSAM Options to buy common stock 40,000 31 Dec 2021 Common Stock 40,000 $0.5 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award of shares was made pursuant to Issuer's board of director's approval under Issuer's restricted stock agreement.
F2 The total holdings reported on previous Form 5 accidentally included 39,760 shares of common stock that Mr. Mayersohn did not hold.
F3 The options vest semi-annually in two equal installments beginning on 02/24/2022.
F4 The total holdings reported on previous Form 5 accidentally reported 2000 less options to buy common stock of the Company.